학술논문
The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib
Document Type
Article
Author
Source
In: Experimental Hematology . (Experimental Hematology, May 2021, 97:57-65.e5)
Subject
Language
English
ISSN
18732399
0301472X
0301472X